Molecular Cytogenetics Market Trends & Analysis

The global Molecular Cytogenetics Market size is estimated at USD 2.59 billion in 2023 and is predicted to reach USD 5.08 billion by 2030 with a CAGR of 10.1% from 2024-2030.

Click Here For Free Sample!

The rising prevalence of diseases such as cancer and sickle cell disease fuels the growth of the industry as it amplifies the need for advanced diagnostic tools and technologies. The rise in such diseases creates need for precise detection of genetic mutations and chromosomal abnormalities provided by molecular cytogenetics.

Moreover, increasing healthcare expenditure is driving molecular cytogenetics market demand due to the growth of advanced diagnostic tools and technologies for precise genetic testing and early detection of diseases.

North America dominates the molecular cytogenetics market share at present and is projected to continue its dominance throughout the forecast period. This dominance is due to the increasing prevalence of down syndrome cases in the countries such as U.S., Canada, and others creates demand for advanced diagnostic methods including molecular cytogenetics.

Molecular cytogenetics industry comprises of several key market players such as Neuberg Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, DSS Imagetech Pvt. Ltd., Bionano Genomics, Inc., Illumina, Inc., Agilent Technologies, Inc, Oxford Gene Technology IP Ltd., Weill Cornell Medicine, Cytotest Inc., and others. These market players are adopting various strategies such as launches and partnerships to maintain their dominance in the industry.